159 related articles for article (PubMed ID: 19406231)
1. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
Subedi RK; Kang KW; Choi HK
Eur J Pharm Sci; 2009 Jun; 37(3-4):508-13. PubMed ID: 19406231
[TBL] [Abstract][Full Text] [Related]
2. α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles.
Oliveira MS; Mussi SV; Gomes DA; Yoshida MI; Frezard F; Carregal VM; Ferreira LAM
Colloids Surf B Biointerfaces; 2016 Apr; 140():246-253. PubMed ID: 26764108
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
[TBL] [Abstract][Full Text] [Related]
5. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
Han Y; Zhang P; Chen Y; Sun J; Kong F
Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded lipid-quantum dot hybrids: surface topography and release properties.
Tian B; Al-Jamal WT; Al-Jamal KT; Kostarelos K
Int J Pharm; 2011 Sep; 416(2):443-7. PubMed ID: 21315141
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of solid lipid nanoparticles containing peptide.
Hu FQ; Hong Y; Yuan H
Int J Pharm; 2004 Apr; 273(1-2):29-35. PubMed ID: 15010127
[TBL] [Abstract][Full Text] [Related]
9. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
[TBL] [Abstract][Full Text] [Related]
10. Core/shell nanoparticles for pH-sensitive delivery of doxorubicin.
Oh KS; Um YS; Lee JH; Cho SH; Lee KE; Han SS; Kim D; Yuk SH
J Nanosci Nanotechnol; 2010 Oct; 10(10):6967-71. PubMed ID: 21137835
[TBL] [Abstract][Full Text] [Related]
11. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
[TBL] [Abstract][Full Text] [Related]
12. Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride.
Vrignaud S; Anton N; Gayet P; Benoit JP; Saulnier P
Eur J Pharm Biopharm; 2011 Sep; 79(1):197-204. PubMed ID: 21345371
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065
[TBL] [Abstract][Full Text] [Related]
14. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting.
Kolluru LP; Rizvi SA; D'Souza M; D'Souza MJ
J Drug Target; 2013 Jan; 21(1):77-86. PubMed ID: 23036042
[TBL] [Abstract][Full Text] [Related]
15. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models.
Oliveira MS; Aryasomayajula B; Pattni B; Mussi SV; Ferreira LAM; Torchilin VP
Int J Pharm; 2016 Oct; 512(1):292-300. PubMed ID: 27568499
[TBL] [Abstract][Full Text] [Related]
17. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
Tinkov S; Winter G; Coester C; Bekeredjian R
J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
[TBL] [Abstract][Full Text] [Related]
18. A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)₃-PLA nanopolymersomes.
Ayen WY; Kumar N
Eur J Pharm Sci; 2012 Aug; 46(5):405-14. PubMed ID: 22465658
[TBL] [Abstract][Full Text] [Related]
19. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
Benival DM; Devarajan PV
Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]